A Study of LY3841136 in Healthy and Overweight Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

148

Participants

Timeline

Start Date

March 30, 2022

Primary Completion Date

January 25, 2024

Study Completion Date

January 25, 2024

Conditions

ObesityHealthy

Interventions

DRUG

LY3841136

Administered SC.

DRUG

Placebo

Administered SC.

Trial Locations (3)

Fortrea Clinical Research Unit, Daytona Beach

Fortrea Clinical Research Unit, Madison

Fortrea Clinical Research Unit, Dallas

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY